Android Mobile Informatics Application for some Hereditary Diseases and Disorders (AMAHD): A complementary framework for medical practitioners and patients  by Oluwagbemi, Olugbenga et al.
Informatics in Medicine Unlocked 2 (2016) 38–69Contents lists available at ScienceDirectInformatics in Medicine Unlockedhttp://d
2352-91
n Corr
E-mjournal homepage: www.elsevier.com/locate/imuAndroid Mobile Informatics Application for some Hereditary Diseases
and Disorders (AMAHD): A complementary framework for medical
practitioners and patients
Olugbenga Oluwagbemi a,n, Folakemi Oluwagbemi b, Chisom Ughamadu c
a Department of Computer Science, Faculty of Science, PMB 1154, Federal University Lokoja, Lokoja, Nigeria
b Department of Information Technology, College of Information and Communication Technology, P.O. Box 1060, Salem University, Lokoja, Nigeria
c Akwa Ibom State Government Ministry of Works, Wellington Bassey Way, PMB 1079, Barracks Road, Uyo, Nigeriaa r t i c l e i n f o
Article history:
Received 29 January 2016
Received in revised form
20 March 2016
Accepted 21 March 2016
Available online 29 March 2016
Keywords:
Hereditary diseases
Android application
Medical practitioners
Informatics
Bioinformatics
Mobile informaticsx.doi.org/10.1016/j.imu.2016.03.001
48/& 2016 Published by Elsevier Ltd. This is a
esponding author.
ail addresses: olugbenga.oluwagbemi@fulbrigha b s t r a c t
Hereditary diseases and disorders constitute a public health problem. Many people in rural communities
of developing countries of the world are particularly ignorant about the cause, modes of transmissions
and the treatment plans for such diseases. In some cases, some people lack essential knowledge between
common and rare hereditary diseases.
It is therefore appropriate and essential to develop a mobile application that will act as an educative
resource and a good knowledge base for common and rare hereditary diseases.
The aim of this research is to develop AMAHD (Android Mobile Informatics Application for some
Hereditary Diseases and Disorders).
The objectives of this research are to create an android mobile application that will act as a reference
point and provide useful information about various hereditary diseases to medical personnel and pro-
fessionals; provide additional educational resource to biological and bioinformatics researchers in dif-
ferent higher institutions; and provide a pedagogical, diagnostic and complementary foundational
learning tool for African research students in biosciences, bioinformatics, and all other categories of
students that currently engage in multidisciplinary research in the aspect of hereditary diseases.
Essential data was sourced from relevant literature. We developed AMAHD through an integration of
programming languages in Java and XML (Extended Markup Language). SQLite was used to implement
the database. We developed a Logical Disjunction Rule-based Algorithm (LDRA) for the AMAHD’s
diagnosis module.
A comparative analysis between existing commercial hereditary mobile applications and AMAHD was
conducted and the results presented. A world-wide online survey (spanning Africa, Asia, Europe, America
and Australia) was conducted to sample the opinion of individuals across the globe on the classiﬁcation
of hereditary diseases as either rare or common, within their respective regions. In addition, an eva-
luation of AMAHD on the ofﬂine platform was conducted by administering paper questionnaires and
asking users direct questions about how they respectively rate the performance of AMAHD based on
certain evaluation criteria. Furthermore, a separate evaluation of AMAHD was conducted using online
survey monkey. Finally, a comparative analysis between the results obtained from the online evaluation
and ofﬂine evaluation of AMAHD was conducted and presented.
The results of the surveymonkey online questionnaire revealed that: 58.49% of the participants
agreed that AMAHD can be used to diagnose users ailments based on the hereditary disease symptoms
they supplied to the mobile application; 13.21% disagreed, while 28.30% of the participants were indif-
ferent. 71.7% of the participants agreed that AMAHD can act as a complementary resource for supple-
mentary healthcare support; 5.66% disagreed, while 22.64% of the participants were indifferent. 88.46%
of the participants agreed that AMAHD can be particularly supportive to developing countries where
there is less awareness of the deadly effects on hereditary diseases; 1.92% disagreed, while 9.62% were
indifferent. Finally, 86.79% of the participants agreed that AMAHD can be useful as an android health
application, 13.21% disagreed.
& 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tmail.org, olugbenga.oluwagbemi@fulokoja.edu.ng, gbemiseun@yahoo.com (O. Oluwagbemi).
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Heredity diseases are diseases inherited by offspring from their
respective parents. Such diseases are transmitted from parents to
offspring. There are thousands of hereditary diseases among
humans; some are common whereas some are not. The most
disturbing thing about these diseases is that scientists are still
trying to decipher the appropriate cure to them. A genetic disorder
connotes an illness that results from one or more abnormalities in
the human genome. Genetic disorders can cause hereditary dis-
eases or it can result from mutations in DNA. Thus, when defective
genes are inherited from parents, or when such defective genes
are dominant, hereditary diseases are the outcome. There are
currently about 4000 hereditary diseases and disorders; more are
still being discovered [1].
A large proportion of deaths in West Africa are traceable to
hereditary diseases. This is a public health problem. Inaccessibility
to information and knowledge about hereditary diseases and
disorders, especially in remote settings of the African continent
constitutes another problem. Professor Ibrahim Gambari, Under
Secretary-General, Special Adviser to the Secretary General of the
United Nations, lamented that: “On Health and Education”, he
said, “the level of immunization of Children against dangerous
childhood diseases, in the South-East is 44.6% immunization cov-
erage, but the North-West has 3.7% and the North-East 3.6%.”
These childhood diseases span hereditary diseases and disorders
[2]. In some situations, medical practitioners who are not knowl-
edgeable, diagnose the wrong disease and prescribe the wrong
medications.
The level of ignorance about hereditary diseases and disorders,
the lack of comprehensive knowledge about its mode and medium
of transmission from one generation to another, is of deep con-
cern, especially among inhabitants of developing African coun-
tries. For instance, sickle cell anemia affects many people across
different continents of the world [3–4]. Thus, it is expedient that
the knowledge of hereditary diseases be made readily available to
rural community dwellers in African regions through a mobile
informatics approach. These are inhabitants that can read, write
and knowledgeable about the use of mobile devices.
With the current trend of software development, focus is gra-
dually shifting rapidly from the web based applications to the
mobile platform, in order to foster portability and ease of access to
these applications. The aim of this research is to develop AMAHD
(Android Mobile Informatics Application for some Hereditary
Diseases and Disorders). This will act as a complementary frame-
work for medical practitioners, patients and inhabitants of com-
munities within Africa and other developing continents of the
world. The mobile application will help to provide detailed infor-
mation about hereditary diseases, their symptoms, corresponding
causes, and how they can be prevented or treated. It can also serve
as a mini-diagnostic tool.
The incidences of genetic diseases between developed and
developing countries differ. For instance, in Japan, they do not
have high incidence of sickle cell anemia compared to African
countries [5]. Different locations have different types of genetic/
hereditary diseases and disorders mostly associated with them.
The objectives of this research are to:
 Create an android mobile application that will act as a reference
point and provide useful information about various hereditary
diseases to medical personnel and professionals
 Provide additional educational resource to biological and
bioinformatics researchers in different higher institutions
 Provide a pedagogical and complementary foundational learn-
ing tool for African research students in biosciences, bioinfor-
matics, and all other categories of students that currentlyengage in multidisciplinary research in the aspect of hereditary
diseases.
The major reason for developing an android mobile informatics
application is due to the wide acceptability and usage of android
mobile applications. In 2012, according to a web design company
based in Dubai [6], it was estimated that 80% of the world popu-
lation now has a mobile phone, out of which only 1.08 billion are
smart phones users. Based on the data compiled on smart phone
user's statistics and facts, the android Smartphone platform has
the highest market share of 46.9%. This growth is being driven by
strong demand for low-cost Smartphone across major regions
such as China, India and Africa. Based on these facts, an android
mobile application was the most suitable platform for the imple-
mentation of AMAHD.
AMAHD contains information on different hereditary diseases
and provides easy access to such information. It especially pro-
vides the information to curious individuals in order to sensitize
them on the negative effects of these diseases. It also acts as a
source of information and awareness to persons living with
common hereditary diseases and disorders. It further acts as a
complementary platform for medical practitioners, those ignorant
of hereditary diseases and bioinformaticians in the areas of pro-
viding a comprehensive repository of knowledge.2. Related works
Two separate reviews were conducted in this study. The ﬁrst
was the scholarly literature review while the second was the
commercial application review.
2.1. Literature review
We searched for mobile application-related literature for pre-
valent hereditary diseases between 2003 and 2015 on the fol-
lowing academic indexing systems and databases: IEEE Explore,
Science Direct, Scopus, PubMed and Web of Knowledge. Some of
the prevalent hereditary diseases were sourced from the WHO
Global Burden of Disease Report of 2004 [7]. From the search, we
discovered that scholarly literature on mobile applications that
dealt with diagnosis and treatments of hereditary diseases were
relatively few. So we decided to focus on the review of commer-
cially available hereditary-disease mobile applications.
2.2. Review of existing commercial mobile applications
From existing literature, we reviewed commercial mobile
applications (from 2003 to 2013) that have been applied to some
hereditary diseases or are still being applied to hereditary diseases
from the application stores of different Smartphone brands [8,9],
such as Google Playstore of Google Android [10], Apple itunes of
Apple [25], BlackBerry World of BlackBerry [26] and Windows
Phone AppsþGames Store of Microsoft [27]. The selected heredi-
tary diseases are migraine [11], low vision [12], sickle cell disease
[13], depression [14–16], asthma [17–20] and diabetes [21–24].
From a previous study conducted by Martinez Perez and collea-
gues [30], we were able to extract the tabulated statistical data for
hereditary-related commercial mobile applications (See Table 1)
with information about mobile applications and the correspond-
ing stores where they were gotten from. After collating the list of
hereditary-disease related mobile applications, we conducted a
simple comparative analysis between existing mobile applications
presented by Martínez-Pérez and colleagues [30] and AMAHD
presented by us. This comparison is depicted in Table 2.
Table 2
Comparative analysis between AMAHD and some selected existing hereditary disease mobile application.
S/N NAME Condition Rating Class Internet
requirement
Clinical/ Non-
clinical
Data Visualization
1 AMAHD Generic (both rare and com-
mon hereditary diseases)
Educational Yes Both Text and photo
Informative Assistive
2 SickleSAM (not
commercial)
Anemia Tracking No Clinical Graph
3 MD Series: Anemia free 4.9 Educational No Both Text
4 iBMM (not commercial) Migraine Educational Guideline
Monitoring
Yes Both Video, text and graph
5 My Headache Log Pro Migraine 4.1 Monitoring Yes (Emails) Both Text and graph
6 VizWiz Low Vision 4.5 Assistive Yes Non Clinical Photos, text and audio
7 EZReader Theme Pack Low Vision 4.4 Assistive No Non Clinical Text and audio
8 m. Carat Asthma Assistive Monitoring Yes Non Clinical Graph, text and
picture
9 SIGN Asthma Patient Guide Asthma 4.9 Informative Guidelines Yes Non Clinical Text and pictures
10 Type 1 diabetes
Friend: Alcohol Guide Diabetes Mellitus Educational
Informative Yes Non Clinical Text and photos
11 On Track Diabetes Diabetes Mellitus 4.5 Monitoring Yes (Emails) Both Text and graphs
12 VirtualClinic – The Get
Happy Program
Depression Educational Guidelines Unknown Non Clinical Pictures, comic and
text
13 Positive thinking Depression 4.3 Treatment Yes Non Clinical Text
Table 1
Results of the hereditary-disease related commercial mobile apps review by Borja Martínez-Pérez and colleagues from 2003 to 2013 Source: (Martínez-Pérez et al. [30]).
Commercial site Anemia Migeraine Low vision Asthma Diabetes Diabetes mellitus Depression
Google Play 7/74 57/201 33/43 44/226 41000 19/67 41000
Itunes 7/21 46/102 30/46 57/124 605 17/21 419
Blackberry 0/0 5/6 0/0 6/7 33 0/0 13
Windows 0/0 4/8 1/1 4/14 81 2/3 69
Nokia Ovis Store 0/0 0/0 – 1/2 40 15/40 35
Total 14 112 64 112 41759 53 41536
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ment, have been conducted in the past. For instance, Arnhold et. al.
[28], conducted an extensive systematic review and expert-based
usability evaluation on android and iOS mobile applications for
diabetes patients. In total, they analyzed 656 apps. Their review
and evaluation results revealed that 355 (representing 54.1%) of
the total mobile apps performed just one function, while 348
(representing 53.0%) performed documentation function. From
their ﬁndings, they discovered that the most prominent and
dominant mobile app language was English with 560 apps
(representing 85.4% of the total mobile apps). Patients were mostly
the users of the apps with 630 (representing 96.0%) of the total
app users. Results also showed that most people (representing
53.7%), tended towards using free mobile apps.
Another mobile application known as MyFactor was developed
by BioRx. MyFactor app was actually designed to help hemophilia
patients manage their health conditions and interact with relevant
healthcare team [29]. MyFactor mobile app was found to be
effective because of its features such as; quick log infusions, ability
to track bleeding episodes, capability to allow viewing and sharing
reports of infusion and bleed history, scheduling infusion remin-
ders, and updating past bleeds or infusions.
2.3. Existing research on mobile health for disease diagnosis and
management
There are many existing research on the application of mobile
health for disease diagnosis and management. In this section, wereviewed some of them. A review was recently conducted by Jutel
and Lupton [61] to describe different diagnosis applications and
highlight their impact on diagnosis process. A new app has been
developed by some researchers in the University of Cambridge. The
purpose of the app is to help monitor disease conditions for patients
and doctors [62]. It has the capability of accurately measuring color-
based test, which can be applied at home, hospital settings, and
remote locations. It can also facilitate effective real-time transfer of
patient medical data to medical practitioners. Some researchers
have applied mobile systems in diabetes management [63]. In
another study, a mobile application for diagnosing preeclampsia
was developed to help people living in settings with limited
resources [64]. Arsand and colleagues developed another mobile
application to help people living with type 2 diabetes to manage-
ment the disease [65]. Harris and colleagues designed a mobile
diabetes management system by focusing on glycemic control in
patients living with diabetes [66]. Lee and colleagues developed a
mobile application game for dietary control of human body weight
[67]. Kulkarnia and Ozturk developed (mPHASiS), a mobile patient
information system which acts as a complementary tool to care-
givers and can be integrated into a hospital information system for
managing chronic diseases of affected patients [68]. Mattila and
colleagues developed a wellness management mobile application
[69]. The mobile application's concept focused on Cognitive-
behavioral therapy(CBT). Logan and colleagues applied mobile
phones to the management of the hypertension in hypertensive
patients [70].
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3.1. Overview of AMAHD
AMAHD can be used by medical practitioners, medical students
in training, patients, and bioinformaticians working in the area of
genetics. It provides comprehensive information about hereditary
diseases. The application consists of the view disease menu,
symptoms menu and the close buttons menu. Within the
application, the classiﬁcations of hereditary diseases were pre-
sented as either rare or common. We classiﬁed the hereditary
diseases into common or rare hereditary diseases, based on the
survey results we were able to collate from online survey parti-
cipants from Africa, Australia, Europe, America, and Asia. These
participants classiﬁed the hereditary diseases based on their
understanding of the frequency of occurrence of such diseases in
their respective regions. This informed our decision of classifying
such hereditary diseases and disorders as either common or rare
in AMAHD (See Figs. 3–16).
The ﬁrst section of AMAHD consists of the rare hereditary
diseases. Among the rare hereditary diseases, as highlighted in our
android mobile application, are: dysplasia, thrombosis, pernicious
Anemia, Parkinson's, methemoglobinemia, Leigh’s, compormelic,
amongst others. The section of AMAHD consists of the common
hereditary diseases. Among some of the common hereditaryFig. 1. Flowchart of AMAHD illustrating tdiseases are: sickle cell, albinism, diabetes, color blindness, bald-
ness, among others. The information about each hereditary disease
provides description about the causes and possible treatments
that can be applied to address such diseases (See Figs. 17 and 18).
The third section of AMAHD is the internet search option. The
purpose of this section is to provide access to hereditary diseases
that have not been listed in AMAHD. This allows any user to
quickly search for information about hereditary diseases by con-
necting to the internet through AMAHD's graphical user interface.
If the hereditary disease exists, then it displays information about
it, but if not, it does not display. The result obtained here is
dependent upon the availability of internet connectivity.
The fourth section of AMAHD is the symptoms section. We
anticipated incorporating artiﬁcial intelligence into AMAHD in
future versions. Therefore, this section is still at the developmental
stage. However, in future versions of AMAHD, we hope to com-
plete the symptoms section. The symptom section prompts the
user to key-in up to four different symptoms and through a
“Logical Disjunction Rule-based algorithm”, AMAHD can suggest
the likely hereditary disease(s) (See Figs. 23 and 24), that has the
symptoms that such users have provided. However, if the her-
editary diseases with such symptoms do not exist in AMAHD’s
database, AMAHD speciﬁcally states that the symptom does not
exist in the database (See Figs. 19–22).he various processes within AMAHD.
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The architecture of AMAHD consists of three (3) major layers
namely: (i) the presentation layer (ii) the application layer and (iii)
the data layer. This architecture helps to depict how the mobile
application works and behaves. According to Kruchten and col-
leagues [31–33], software architecture of a system encompasses
the composition of the structural and behavioral elements of theFig. 2. Overview of AMAHD illustrating the various sectionsystem. The functionalities that AMAHD provides are: viewing,
entering and searching for information on hereditary diseases.
AMAHD gets its data from a local database and the internet.
3.3. Implementation
Eclipse Integrated Development Environment (Eclipse IDE) was
used for developing AMAHD. An integration of Java and XMLs within AMAHD – view disease, symptoms and close.
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implement AMAHD. Android java source code was used to create the
application. XML was used for designing the structure of the interface.
SQLite was used for the database aspect of the android application. A
logical deductive reasoning algorithm was developed and used to
implement the symptoms section (See Section 3.3.2). BlueStacks App
Player was used to emulate and simulate AMAHD on windows 7 and
8 operating systems. The implementation of AMAHD can also be
viewed on the AMAHD ﬂowchart as shown in Fig. 1. The ﬂowchart
begins with the overview section. It progresses by leading users to
either view common diseases or rare diseases. If diseases are found, it
displays information about such hereditary diseases. If not found, it
provides opportunity for the users to search for the hereditary dis-
eases. On the second front, if users are interested in keying symptoms,
then AMAHD uses a logical rule-based algorithm as speciﬁed in Sec-
tion 3.3.2 (See Listing 1), to infer the possible hereditary disease whose
symptoms have been keyed into the application.
3.3.1. Implementation details of AMAHD
Java programming language was used for implementing the
presentation for each type of hereditary disease included in
AMAHD. They are then linked up with information about them on
the database or on the internet. For the implementation of the
database in AMAHD, these have been speciﬁed in the code listings.
Few of the code listings for it can be viewed in the appendix
section. However, a comprehensive list of all the codes for AMAHD
can be made available upon request from the corresponding
author.Fig. 3. Regions of the world that participated in the classiﬁcation of some selected hered
presented to participants to classify as either rare or common within their respective re
classiﬁcation, with majority from West Africa.3.3.2. Algorithm
A logical deduction mechanism was built into AMAHD by devel-
oping a logical disjunction-based algorithm that allows a user to enter
up to four symptoms. AMAHD uses this algorithm to compare these
symptoms with an existing database that has a list of hereditary dis-
eases, with corresponding sets of possible symptoms. AMAHD now
uses the algorithm to search through the database to select corre-
sponding hereditary diseases that have such symptoms as entered by
the user of the mobile application. The algorithm is based on the
principle of logical disjunction and it is valid. For this reason, we have
named our algorithm a “Logical Disjunction Rule-based Algorithm”
(LDRA). The algorithm applies logical reasoning based on the princi-
ples of logical disjunction, by providing a set of possible hereditary
diseases, whose symptoms are in common with the symptoms keyed
in by the user into AMAHD (See Figs. 19–22) and (Figs. 23–24). The
concept of 2 to the power of n ð2nÞ has many applications in computer
science [47–49]. We adopted the concept of 2 to the power of n ð2nÞ
for the current number of symptoms that the algorithm can accom-
modate. Here, n¼ 2, thus we have 22 ¼ 4. We hope to build and
implement a more robust version of this algorithm in the order of
28;216;224;230; :::::::21024::::;274;207;281 in future multi-lingual version of
AMAHD. The last value of 274;207;281¼300,376,418,
084,606,182,052,986,................., 498, 687, 010, 073, 391, 086, 436,352.
This ﬁnal value has more than 22 million digits [50–53]. The (LDRA)
algorithm is depicted as shown in Listing 1.itary diseases and disorders. Some selected hereditary diseases and disorders were
gions. Participants from Africa, America, Europe, Asia and Australia took part in the
Listing 1. Logical Disjunction Rule-based Algorithm (LDRA).
Begin
Enter symptom1, symptom2, symptom3, symptom4
Search for hereditary disease in the disease database having at least one of these symptoms
If (symptom1 or symptom2 or symptom3 or symptom4 is present) in the hereditary disease
database
OR
If all the symptoms are found in any of the hereditary diseases and disorders,
then output hereditary_disease1/disorder1,
hereditary_disease2/disorder2,
hereditary_disease3/disorder3
hereditary_disease4/disorder4
that contains any of the symptoms searched for
Else
Output The hereditary diseases for these symptoms NOT found
End
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Discrete Mathematics,
If n¼number of symptoms entered, then the number of
possible outputs will be 2n possible outputs. Deductive rea-
soning (which is also referred to as logical deduction or top-
down logic), is a reasoning procedure from one or more state-
ments (premises) to arrive at a logically sure conclusion. Thus,
deductive reasoning creates a bridge that links premises toFig. 4. Depiction of the percentages of those that classiﬁed Thrombosis as either a rare
majority classiﬁed Thrombosis as a rare hereditary disease/disorder in their respectiveconclusions [54–57]. We adopted the knowledge of deductive
reasoning in this algorithm.
From the knowledge of logical reasoning and logical dis-
junction [58,59], if n¼2, then the truth table will generate 22¼4
possible outputs. However, if n¼3, then the truth table is capable
of generating 23¼8 possible outputs. If n¼4, then the truth table
is capable of generating 24¼16 possible outputs. For a set A with n
elements, the cardinality of 2A is 2n. This is in fact the reason foror a common hereditary disease/disorder. The results of the survey showed that
regions than others.
Fig. 5. Depiction of the percentages of those that classiﬁed Hutchinson as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Hutchinson as a rare hereditary disease/disorder in their respective regions.
Fig. 6. Depiction of the percentages of those that classiﬁed Dysplasia as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Dysplasia as a rare hereditary disease/disorder in their respective regions.
Fig. 7. Depiction of the percentages of those that classiﬁed Trenaunay as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Trenaunay as a rare hereditary disease/disorder in their respective regions.
Fig. 8. Depiction of the percentages of those that classiﬁed Leighs as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Leighs as a rare hereditary disease/disorder in their respective regions.
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Fig. 9. Depiction of the percentages of those that classiﬁed Usher syndrome as either a rare or a common hereditary disease/disorder. The results of the survey showed that
more people classiﬁed Usher syndrome as a rare hereditary disease/disorder in their respective regions.
Fig. 10. Depiction of the percentages of those that classiﬁed Myastenia as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Myastenia as a rare hereditary disease/disorder in their respective regions.
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Fig. 11. Depiction of the percentages of those that classiﬁed Pernicious Anemia as either a rare or a common hereditary disease/disorder. The results of the survey showed
that more people classiﬁed Pernicious Anemia as a rare hereditary disease/disorder in their respective regions.
O. Oluwagbemi et al. / Informatics in Medicine Unlocked 2 (2016) 38–6948the power set notation. Back to our proposed algorithm (LDRA),
the principle of operation is similar to deductive logical reasoning.
We developed this algorithm based on the principle of logical
deduction, logical disjunction to be speciﬁc. We now married this
principle to logic programming.
We have some assumptions here. They are:
 An hereditary disease may have more than one symptoms
 An hereditary disease may share more than one symptom in
common with another hereditary diseases.
However, if n¼ 4, then the logical truth table is capable of
generating 24¼16 possible outputs. This particular condition is in
perfect correlation and depiction with our proposed algorithm.
Here, we have the truth table highlighted in Table 4.4. There are
16 possible outcomes here.
The following propositions hold about the premises P, Q, R
and S:
P is True – if symptom 1 exists in the hereditary disease
database. If it does not exist, then P is false.
Q is True – if symptom 2 exists in the hereditary disease
database. If it does not exist, then Q is false.
R is True – if symptom 3 exists in the hereditary disease
database. If it does not exist, then R is false.
S is True – if symptom 4 exists in the hereditary disease data-
base. If it does not exist, then S is false.
The following logical conclusions are valid after applying
the principle of logical disjunction for the premises P, Q, R
and S. Remark 1 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 exists in the hereditary
disease database, or if symptom 3 exists in the hereditary
disease database or if symptom 4 exists in the disease
database, then it still returns a truth value of (T) (See Table 4.4).
Returning this truth value implies that it returned a set of
possible hereditary diseases which have all of the four symp-
toms within the hereditary disease database or share all the
four symptoms in common within the hereditary database.
According to the rule of logical disjunction, this is logically
valid. In fact, in logic, this is referred to as the truth-preserving
validity [60]. In logic, an argument is valid if and only if the
truth of its premises entails or results into the truth of its
conclusion.
 Remark 2 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 exists in the hereditary dis-
ease database, or if symptom 3 exists in the hereditary disease
database or if symptom 4 DOES NOT exist in the disease data-
base, then it still returns a truth value of (T) (See Table 4.4).
Returning this truth value implies that it returned a set of
possible hereditary diseases which have all of the three symp-
toms within the hereditary disease database or share all the
three symptoms in common within the hereditary disease
database. According to the principle of logical disjunction, this
is logically valid.
 Remark 3 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 exists in the hereditary dis-
ease database, or if symptom 3 DOES NOT exist in the hereditary
disease database or if symptom 4 exists in the hereditary dis-
ease database, then it still returns a truth value of (T) (See
Table 4.4). Returning this truth value implies that it returned a
Fig. 12. Depiction of the percentages of those that classiﬁed Methemoglobinemia as either a rare or a common hereditary disease/disorder. The results of the survey showed
that more people classiﬁed Methemoglobinemia as a rare hereditary disease/disorder in their respective regions.
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symptoms within the hereditary disease database or share all
the three symptoms in common within the hereditary disease
database. According to the principle of logical disjunction, this is
logically valid.
 Remark 4 implies that if symptom 1 exists in the hereditary disease
database or if symptom 2 exists in the hereditary disease database,
or if symptom 3 DOES NOT exist in the hereditary disease database
or if symptom 4 DOES NOT exist in the hereditary disease database,
then it still returns a truth value of (T) (See Table 4.4). Returning this
truth value implies that it returned a set of possible hereditary
diseases which have all of the two symptoms within the hereditary
disease database or share all the two symptoms in commonwithin
the hereditary disease database. According to the principle of logical
disjunction, this is logically valid.
 Remark 5 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 DOES NOT exist in the her-
editary disease database, or if symptom 3 exists in thehereditary disease database or if symptom 4 exists in the her-
editary disease database, then it still returns a truth value of (T)
(See Table 4.4). Returning this truth value implies that it
returned a set of possible hereditary diseases which have all
of the three symptoms within the hereditary disease database
or share all the three symptoms in common within the
hereditary disease database. According to the principle of logical
disjunction, this is logically valid.
 Remark 6 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 DOES NOT exist in the her-
editary disease database, or if symptom 3 exists in the heredi-
tary disease database or if symptom 4 DOES NOT exist in the
hereditary disease database, then it still returns a truth value of
(T) (See Table 4.4). Returning this truth value is logical and this
implies that it returned a set of possible hereditary diseases
which have at least one of the symptoms within the hereditary
disease database. According to the principle of logical disjunc-
tion, this is logically valid.
Fig. 14. Depiction of the percentages of those that classiﬁed Sickle Cell as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Sickle Cell as a common hereditary disease/disorder in their respective regions.
Fig. 13. Further Regions of the world that participated in the classiﬁcation of some selected hereditary diseases and disorders. Some selected hereditary diseases and
disorders were presented to participants to classify as either rare or common within their respective regions. Participants from Africa, Europe, and Asia took part in the
classiﬁcation, with majority from West Africa.
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Fig. 16. Depiction of the percentages of those that classiﬁed Depression as either a rare or a common hereditary disease/disorder. The results of the survey showed that
approximately equal number of people classiﬁed Depression as a common and rare hereditary disease/disorder in their respective regions.
Fig. 15. Depiction of the percentages of those that classiﬁed Diabetes as either a rare or a common hereditary disease/disorder. The results of the survey showed that more
people classiﬁed Diabetes as a common hereditary disease/disorder in their respective regions.
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Fig. 17. Depiction of an overview of AMAHD highlighting section for common hereditary diseases. An overview of AMAHD showing the section for common hereditary
diseases and disorders.
Fig. 18. Depiction of an overview of AMAHD highlighting section for rare hereditary diseases. An overview of AMAHD showing the section for rare hereditary diseases and disorders.
O. Oluwagbemi et al. / Informatics in Medicine Unlocked 2 (2016) 38–6952 Remark 7 implies that if symptom 1 exists in the hereditary
disease database or if symptom 2 DOES NOT exist in the her-
editary disease database, or if symptom 3 DOES NOT exist in the
hereditary disease database or if symptom 4 exists in the her-
editary disease database, then it still returns a truth value of (T)(See Table 4.4). Returning this truth value is logical and this
implies that it returned a set of possible hereditary diseases
which have at least two of the symptoms are within the
hereditary disease database. According to the principle of logical
disjunction, this is logically valid.
Fig. 19. Symptoms entered into AMAHD. The four (4) separate symptoms entered into AMAHD for this segment include: pain in the joint, cold, dizziness, and blurred vision.
AMAHD uses a logical disjunction rule-based algorithm to process these symptoms.
Fig. 20. AMAHD predicting no possible hereditary disease(s)/disorder(s). Here AMAHD returned no result because the logical disjunction rule-based algorithm found no
symptom, (as entered by the user), in common with the hereditary disease database.
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Fig. 21. AMAHD’s symptom section revealing that symptom section was empty. This symptom section of AMAHD reveals that no symptom was entered.
Fig. 22. AMAHD’s section revealing that no symptom was entered. The symptom section of AMAHD displayed that no symptom was entered, thus no result to display
possible hereditary diseases/disorders.
Fig. 23. Extra symptoms entered into AMAHD. The four (4) separate symptoms entered into AMAHD for this segment include: memory loss, itchy nose, strokes and bleeding.
AMAHD uses a logical disjunction rule-based algorithm to process these symptoms.
O. Oluwagbemi et al. / Informatics in Medicine Unlocked 2 (2016) 38–69 55 Remark 8, (See Table 4.4), implies that if symptom 1 exists in
the hereditary disease database or if symptom 2 DOES NOT exist
in the hereditary disease database, or if symptom 3 DOES NOT
exist in the hereditary disease database or if symptom 4 DOES
NOT exist in the hereditary disease database, then it still returns
a truth value of (T). Returning this truth value is logical and this
implies that it returned a set of possible hereditary diseases
which have at least two of the symptoms are within the
hereditary disease database. According to the principle of logical
disjunction, this is logically valid.
 Remark 9, (See Table 4.4), implies that if symptom 1 DOES NOT
exist in the hereditary disease database or if symptom 2 exists
in the hereditary disease database, or if symptom 3 exists in the
hereditary disease database or if symptom 4 exists in the
hereditary disease database, then it still returns a truth value
of (T). Returning this truth value is logical and this implies that
it returned a set of possible hereditary diseases which have at
least two of the symptoms are within the hereditary disease
database. According to the principle of logical disjunction, this is
logically valid. Remark 10, (See Table 4.4), implies that if symptom 1 DOES
NOT exist in the hereditary disease database or if symptom
2 exists in the hereditary disease database, or if symptom
3 exists in the hereditary disease database or if symptom 4 DOES
NOT exist in the hereditary disease database, then it still returns
a truth value of (T). Returning this truth value is logical and this
implies that it returned a set of possible hereditary diseases
which have at least two of the symptoms are within the
hereditary disease database. According to the principle of logical
disjunction, this is logically valid.
 Remark 11, (See Table 4.4), implies that if symptom 1 DOES NOT
exist in the hereditary disease database or if symptom 2 exists
in the hereditary disease database, or if symptom 3 DOES NOT
exist in the hereditary disease database or if symptom 4 exists
in the hereditary disease database, then it still returns a truth
value of (T). Returning this truth value is logical and this implies
that it returned a set of possible hereditary diseases which have
at least two of the symptoms are within the hereditary disease
database. According to the principle of logical disjunction, this is
logically valid.
Fig. 24. Predicted possible hereditary diseases/disorders. The four (4) possible hereditary diseases/disorders predicted by the logical disjunction rule-based algorithmwithin
AMAHD. The four possible hereditary diseases/disorders are: Pick disease, Hay fever, Sickle Cell, and Miscarriage.
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NOT exist in the hereditary disease database or if symptom
2 exists in the hereditary disease database, or if symptom
3 DOES NOT exist in the hereditary disease database or if
symptom 4 DOES NOT exist in the hereditary disease database,
then it still returns a truth value of (T). Returning this truth
value is logical and this implies that it returned a set of
possible hereditary diseases which have at least two of the
symptoms are within the hereditary disease database.
According to the principle of logical disjunction, this is
logically valid.
 Remark 13, (See Table 4.4), implies that if symptom 1 DOES
NOT exist in the hereditary disease database or if symptom
2 DOES NOT exist in the hereditary disease database,
or if symptom 3 exists in the hereditary disease database
or if symptom 4 exists in the hereditary disease database,
then it still returns a truth value of (T). Returning this
truth value is logical and this implies that it returned a set of
possible hereditary diseases which have at least two of
the symptoms are within the hereditary disease database.
According to the principle of logical disjunction, this is
logically valid.
 Remark 14, (See Table 4.4), implies that if symptom 1 DOES
NOT exist in the hereditary disease database or if symptom
2 DOES NOT exist in the hereditary disease database, or if
symptom 3 exists in the hereditary disease database or if
symptom 4 DOES NOT exist in the hereditary disease database,
then it still returns a truth value of (T). Returning this truth
value is logical and this implies that it returned a set of
possible hereditary diseases which have at least two of thesymptoms are within the hereditary disease database.
According to the principle of logical disjunction, this is
logically valid.
 Remark 15, (See Table 4.4), implies that if symptom 1 DOES
NOT exist in the hereditary disease database or if symptom
2 DOES NOT exist in the hereditary disease database, or if
symptom 3 DOES NOT exists in the hereditary disease database
or if symptom 4 exists in the hereditary disease database, then
it still returns a truth value of (T). Returning this truth value is
logical and this implies that it returned a set of possible
hereditary diseases which have at least two of the symptoms
are within the hereditary disease database. According to the
principle of logical disjunction, this is logically valid.
 Remark 16 implies that if symptom 1 DOES NOT exist in the
hereditary disease database or if symptom 2 DOES NOT exist in
the hereditary disease database, or if symptom 3 DOES NOT
exist, or if symptom 4 DOES NOT exist in the hereditary disease
database, then it returns a false value (F). This is when our
proposed algorithm will select the ELSE part of the imple-
mentation and will not return anything as the output Or it
produces the message “The hereditary diseases for these
symptoms NOT found”, if four (4) symptoms were originally
entered, and they do NOT all exist in the hereditary disease
database. According to the principle of logical disjunction, this is
logically valid. In fact, it is referred to as the false-preserving
validity [60].
For a truth-preserving validity, the interpretation under which
all variables are assigned a truth value of 'true' produces a truth
value of 'true' [60].
Table 3
Analysis of features between AMAHD and some selected existing hereditary disease mobile applications.
S/N NAME Context awareness Therapist intervention Interraction with users Frequency Interface Public
1 AMAHD User Yes Yes Continuous Simple intuitive General
2 SickleSAM (Not commercial) User Yes No Continuous Simple School Children
3 MD Series: No – No Occasional Not intuitive Anemia Specialist
4 iBMM (not commercial) No Yes No Frequency of Migraine attacks Not intuitive General
5 My Headache Log Pro Preferences Location Possible No Frequency of Migraine attacks Complex General
6 VizWiz Location No Yes Frequent Simple General
7 EZReader Theme Language No No Need for arises Basic General
8 m. Carat User Preferences Language No No Constant Complex General
9 SIGN Asthma Patient Guide NO No Guidelines No Occasionally Basic General
10 Type 1 diabetes Friend: Alcohol Guide No No No Occasional Simple Young people
11 On Track Diabetes Preferences Possible No Several times Normal General
12 VirtualClinic – The Get Happy Program Unknown No No Regular Simple General
13 Positive thinking Preferences No No Regular Simple General
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Table 4.1
Interpretation of criteria used for AMAHD's performance evaluation.
S/N Evaluation criteria Interpretation
1 Ability This criterion checks whether AMAHD has the ability to identify or diagnose users ailments based on the symptoms they have supplied to the
mobile app.
2 Data validation 1 This criterion helps to check whether AMAHD accepts appropriate data type for each ﬁeld.
3 Data validation 2 This criterion helps to ascertain if AMAHD prompts error message whenever wrong data is supplied or when important input ﬁelds are
omitted.
4 Sufﬁciency This criterion helps users to check if AMAHD is sufﬁciently robust.
5 Security This criterion is proﬁtable in ascertaining whether AMAHD possesses adequate access control (security).
6 Intension of use This criterion is proﬁtable in ascertaining whether AMAHD will act as a complementary resource for supplementary healthcare support.
7 Ease of use This Ease of Use criterion helps to check if AMAHD is generally simple to explore without any difﬁculty.
8 Satisfaction This criterion helps to ascertain if users are actually satisﬁed with the services and operations provided by AMAHD.
9 Supportiveness This criterion checks if AMAHD will be particularly supportive to developing countries with high rates of unawareness of the deadly effects on
hereditary diseases.
10 Usefulness This criterion helps to check if AMAHD would be useful as a mobile android health application.
Table 4.2
Demography on Off-line Paper questionnaire performance evaluation of AMAHD.
Participants Numbers Types of participants [profession] Age [Bracket] Gender [M¼MALE & F¼FEMALE]
Medical Professionals 60 Doctors – 40 30–60 M¼30 F¼10
Nurses – 20 25–40 M¼ 2 F¼18
Researchers 30 University researchers 30–50 M¼25 F¼5
Community inhabitants 70 Inhabitants of sub-urban areas with android devices (other diverse professions) 16–20 M¼6 F¼6
30–50 M¼36 F¼4
50–60 M¼9 F¼9
Students 40 Medical Students – 15 23–27 M¼ 10 F¼5
Other students – 25 18–24 M¼15 F¼10
Total 200
Table 4.3
Comparison between ofﬂine paper-based survey and online survey monkey performance evaluation survey.
Criteria for performance
evaluation
Survey type Percentage of participants in
Agreement
Percentage of participants in
Disagreement
Percentage of participants that were
indifferent
1. Ability Ofﬂine survey 72.5% 21.5% 6%
Survey monkey 58.49% 13.21% 28.30%
2. Data validation1 Ofﬂine survey 69% 14.5% 16.5%
Survey monkey 58.49% 3.78% 37.74%
3. Data validation2 Ofﬂine survey 37.5% 22% 40.5%
Survey monkey 47.17% 11.32% 41.51%
4. Sufﬁciency [robustness] Ofﬂine survey 62.5% 11.5% 26%
Survey monkey 52.83% 15.09% 32.08%
5. Security Ofﬂine survey 65.5% 10% 24.5%
Survey monkey 64.15% 7.55% 28.30%
6. Intention of use Ofﬂine survey 79.5% 7% 13.5%
Survey monkey 71.7% 5.66% 22.64%
7. Ease of use Ofﬂine survey 67.5% 20.5% 12%
Survey monkey 73.58% 3.78% 22.64%
8. Satisfaction Ofﬂine survey 73.5% 11% 15.5%
Survey monkey 64.15% 5.66% 30.19%
9. Supportiveness Ofﬂine survey 81% 5.5% 13.5%
Survey monkey 88.46% 1.92% 9.62%
10. Usefulness Ofﬂine survey 73% 12% 15%
Survey monkey 86.79% 13.21% 0%
Table 4.4
Possible outcomes of the Logical disjunction rule-based algorithm truth table.
P Q R S PVQ RVS (PVQ) V (RVS) Remarks
T T T T T T T Remark 1
T T T F T T T Remark 2
T T F T T T T Remark 3
T T F F T F T Remark 4
T F T T T T T Remark 5
T F T F T T T Remark 6
T F F T T T T Remark 7
T F F F T F T Remark 8
F T T T T T T Remark 9
F T T F T T T Remark 10
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Table 4.4 (continued )
P Q R S PVQ RVS (PVQ) V (RVS) Remarks
F T F T T T T Remark 11
F T F F T F T Remark 12
F F T T F T T Remark 13
F F T F F T T Remark 14
F F F T F T T Remark 15
F F F F F F F Remark 16
Fig. 25. Evaluation results to show the usefulness of AMAHD. Depiction of survey results to check if AMAHD will be useful as an android mobile health application.
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all variables are assigned a truth value of 'false' produces a truth
value of 'false' [60].
Looking critically at the Table 4.4, Remark 1 has a truth-
preserving validity; it is valid and sound. Remarks 2–15 are
valid. Remark 16 has a false-preserving validity [60].4. Results
4.1. Summary of ﬁndings
AMAHD can be downloaded from Google Play through the link:
https://play.google.com/store/apps/details?id¼com.manish.
customnew&hl¼ﬁl
First, we present the results showing the classiﬁcation of her-
editary diseases as either common or rare hereditary diseases.In the ﬁrst phase of this survey, 87 people participated in
classifying the hereditary diseases as either common or rare.
Furthermore, in the second phase of the survey, 100 people par-
ticipated in classifying the hereditary diseases as either a common
type or a rare type within their respective regions. These results
can be seen as shown in Figs. 3–16.
Second, we present the results showing the comparative ana-
lysis between AMAHD and other selected existing hereditary-
disease mobile applications. These can be found in Tables 2 and 3.
Third, Figs. 3, 35 and 36 shows the various snapshots of the
graphical user interfaces of AMAHD. Fig. 3 is an overview of the
graphical user interface of AMAHD; this ﬁgure presents informa-
tion about the view disease menu, symptoms menu and the close
button menu. Fig. 35 shows the view diseases section. This section
provides users with the opportunity to view information about
hereditary diseases speciﬁcally under the rare category. Three
categories exist namely: the rare, the common and the quick
Fig. 26. Evaluation results to show the ability of AMAHD. Depiction of survey results to check if AMAHD has the ability to identify or diagnose user ailments based on
symptoms entered by respective patients.
Fig. 27. Evaluation results to show AMAHD’s data validation 1 quality. Depiction of survey results to check if AMAHD can accept the appropriate data type for each ﬁeld.
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Fig. 28. Evaluation results to show AMAHD’s data validation 2 quality. Depiction of survey results to check if AMAHD prompts error message whenever wrong data is
supplied or when important input ﬁelds are omitted.
Fig. 29. Evaluation results to show AMAHD’s robustness (sufﬁciency) quality. Depiction of survey results to check if AMAHD is sufﬁciently robust.
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Fig. 30. Evaluation results to show AMAHD’s security quality. Depiction of survey results to check if AMAHD possesses adequate access control.
Fig. 31. Evaluation results to show AMAHD’s quality of intention of use. Depiction of evaluation results to check if AMAHD will act as a complementary resource for
supplementary healthcare support.
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Fig. 32. Evaluation results to show if AMAHD’s Ease of Use quality. Depiction of evaluation results to check if AMAHD will be simple to explore without experiencing any
difﬁculty.
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editary diseases.
Fourth, in order to evaluate the performance of AMAHD, some
usability criteria were adopted. Some of these criteria have successfully
been applied in previous studies. In the works conducted by Bertoa
and Vallecillo; Bertoa and colleagues; Jah; Seffah and colleagues, some
of these evaluation criteria were used [34–37]. A comprehensive off-
line and online user-evaluation of the performance of AMAHD was
conducted, by administering questionnaires to medical professionals,
researchers, community inhabitants, and students. This was done by
manually providing themwith AMAHD. AMAHD was also installed on
their various mobile devices and laptops. Figs. 25–34 show the survey
monkey online performance evaluation results. See also the Excel
Sheet (Updated Evaluation analysis.xls), for the ofﬂine paper perfor-
mance evaluation of AMAHD. Table 4.1 shows the criteria used for the
performance evaluation.
Finally; Table 4.3 shows the results of the comparative analysis
between the ofﬂine paper survey and the online survey monkey
survey.
4.2. Demographic Information about users that participated in the
paper [Off-line] performance evaluation of AMAHD
Participants of the ofﬂine survey were mostly from south-
western Nigerian States and their demography has been depicted
in Table 4.2 (See also the Excel Sheet Updated Evaluation analysis.
xls).
The results of the ofﬂine questionnaire papers administered
during AMAHD's performance evaluation revealed that: 72.5%ofthe participants agreed that AMAHD had the ability to diagnose
and guess users ailments based on the hereditary disease symp-
toms they keyed into AMAHD; 21.5% disagreed, while 6% of the
participants were indifferent. In the criterion of data validation1,
69% of the participants agreed that AMAHD accepted appropriate
data type for each ﬁeld within the mobile application, 14.5% dis-
agreed, 16.5% were indifferent. In the criterion of data validation2,
37.5% of the participants agreed that AMAHD prompted error
messages whenever they supplied wrong data or when they
omitted important input ﬁelds, 22% disagreed, while 40.5% were
indifferent. On the criterion of sufﬁciency, 62.5% of the participants
agreed that AMAHD was sufﬁciently robust. 11.5% disagreed, while
26% were indifferent. On the criterion of security, 65.5% of the
participants agreed that AMAHD possessed adequate access con-
trol, while 10% disagreed and 24.5% of the participants were
indifferent.
79.5% of the participants agreed that AMAHD can act as a
complementary resource for supplementary healthcare support,
7% disagreed, while 13.5% were indifferent. 67.5% agreed that
AMAHD was generally simple to explore without any difﬁculty,
20.5% disagreed, while 12% were indifferent. 73.5% of the partici-
pants agreed that they were satisﬁed with the services and
operations provided by AMAHD, 11% disagreed, while 15.5% were
indifferent. On the criteria of support, 81% of the participants
agreed that AMAHD will be particularly supportive to developing
countries where there is less awareness of the deadly effects of
hereditary diseases, 5.5% disagreed, while 13.5% were indifferent.
Finally, 73% of the participants agreed that AMAHD will be useful
Fig. 33. Evaluation results to show AMAHD’s quality of satisfaction. Depiction of evaluation results to check if users were satisﬁed with the services offered by AMAHD.
O. Oluwagbemi et al. / Informatics in Medicine Unlocked 2 (2016) 38–6964as an android mobile health application, 12% disagreed, while 15%
were indifferent.
4.3. Information about the users that participated in the online
survey monkey evaluation
About 100 participants participated in the general online sur-
vey monkey questionnaire on hereditary disease classiﬁcation and
AMAHD evaluation. 53 of these participants participated in the
performance evaluation of AMAHD and they are from the fol-
lowing regions of the world: West Africa, America, Asia, Europe
and Australia, with the majority from West African countries. The
graphical charts of the results are displayed in Figs. 25–34.
The results of the online survey monkey questionnaire admi-
nistered during AMAHD performance evaluation with 53 partici-
pants, revealed that: 58.49% of the participants agreed that
AMAHD had the ability to diagnose and guess users ailments
based on the hereditary disease symptoms they keyed into
AMAHD, 13.21% disagreed, while 28.30% were indifferent. On the
criteria of data validation1, 58.49% of the participants agreed that
AMAHD accepted appropriate data type for each ﬁeld within the
mobile application, 3.78% disagreed, 37.74% were indifferent. On
the criteria of data validation2, 47.17% of the participants agreedthat AMAHD prompted error messages whenever wrong data was
supplied or when important input ﬁelds were omitted by them,
11.32% disagreed, while 41.51% were indifferent. 52.83% of the
participants agreed that AMAHD was sufﬁciently robust, 15.09%
disagreed, while 32.08% were indifferent. On the aspect of security,
in terms of possessing adequate access control, 64.15% of the
participants agreed that AMAHD possessed adequate access con-
trol, while 7.55% disagreed and 28.30% were indifferent. 71.7% of
the participants agreed that AMAHD can act as a complementary
resource for supplementary healthcare support, 5.66% disagreed,
while 22.64% were indifferent. On the ease of use criterion of
AMAHD, 73.58% of the participants agreed that AMAHD was
generally simple to explore without any difﬁculty, 3.78% disagreed,
while 22.64% were indifferent. On the criterion of satisfaction,
64.15% of the participants agreed that they were satisﬁed the
services and operations provided by AMAHD, 5.66% disagreed,
while 30.19% were indifferent. 88.46% of the participants agreed
that AMAHD will be particularly supportive to developing coun-
tries where there is less awareness of the deadly effects of her-
editary diseases, 1.92% disagreed, while 9.62% were indifferent.
Finally, 86.79% of the participants agreed that AMAHD will be
useful as an android mobile health application, while 13.21% dis-
agreed (Fig. 25).
Fig. 34. Evaluation results to show AMAHD’s quality of supportiveness. Depiction of evaluation results to check if AMAHD will be particularly supportive to inhabitants of
developing countries where some of such inhabitants are less aware about the deadly effects of such diseases.
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5.1. Comparative analysis of AMAHD with other hereditary disease
mobile applications
It is interesting to note that AMAHD has a generic nature which
is quite different from other twelve hereditary-disease mobile
applications. This is evident in the table of comparative analysis as
depicted in Table 2 and Table 3. The purpose of AMAHD is for
educative and informative purposes. Thus, AMAHD is dual purpose
unlike other mobile applications which are of singular purpose.
AMAHD needs internet connectivity to function like the four other
mobile applications in Table 2. In situations where hereditary
diseases searched for do not exist in AMAHD, if there is internet
connectivity, users can connect to the internet through AMAHD.
AMAHD can be used both for clinical and non-clinical purposes.
Similar to the other twelve mobile applications in Table 2, AMAHD
displays its results by text and data visualization.
In comparison with twelve other hereditary-disease mobile
applications, AMAHD is a mobile application that can be used by
different categories of people. Unlike other mobile applications
that are complex and non-intuitive, AMAHD has a simple and
intuitive interface (See Table 3). AMAHD has a continuous usage ascompared with other hereditary disease-related mobile applica-
tions, because it can be used as an educative tool for biomedical
students and bioinformatics researchers specializing in genetics.
Thus, it is a rich resource that can provide complementary fra-
mework to those in the biological sciences and biomedical
profession.
AMAHD can be used as a complementary resource by medical
professionals, and it can also be used by inquisitive individuals
seeking knowledge about common and rare hereditary diseases.
AMAHD interacts with users by prompting them to keyin symp-
toms and displays results to them. From the list in Table 3, only
VizWiz and AMAHD can interact with users. AMAHD was per-
ceived by users as a useful, supportive and complementary
android mobile application for hereditary diseases and disorders.
Many agreed that AMAHD was easy to use.
AMAHD has the capability to provide easily accessible infor-
mation to rural community dwellers through their various android
devices. It is a rich knowledge base that can provide information
about hereditary diseases to Africans and residents of other
developing countries around the world.
AMAHD can be operated on android mobile devices; it can also
be operated and viewed on laptops by ﬁrst installing a mobile
Fig. 36. Overview of Common Hereditary Diseases within AMAHD.
Fig. 35. Overview of Rare Hereditary Diseases within AMAHD.
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application.5.2. Impact on public health
Development and implementation of AMAHD can help dis-
cover hidden information about common and rare hereditarydiseases. This will help translate into a positive knowledge revo-
lution in the aspect of public health. This has the tendency of
promoting healthy living habits among individuals.
Second, AMAHD provides a platform to educate and promote the
use of health-related resources on mobile and hand-held devices.
Public health outcomes become impressive as a result of commu-
nities that beneﬁt and get impacted by the mobile application.
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A healthy nation is a great and prosperous nation. The AMAHD
application, when put to use by many communities in African
countries, and other developing nations of the world, can help
promote health of citizens; this will in turn have positive impact
on the economy of such nations.
5.4. Comparative analysis between the ofﬂine paper survey results
and the online survey monkey survey results
Comparison between the ofﬂine paper survey and the online
survey monkey evaluation of AMAHD, revealed that in terms of
supportiveness, intention of use, security, ease of use, satisfaction,
and usefulness; the participants in the two separate surveys were
in agreement. The percentages of their agreement were of close
proximity (See Table 4.3). However, they had varying range of
disagreements, probably due to the scope of coverage. The ﬁrst
survey was conducted among the inhabitants of southwest
Nigeria, while the second survey was conducted among inhabi-
tants of West African countries, America, Asian countries, and
European countries. Majority of the respondents were from West
African countries.
5.5. The contribution of m-health applications to healthcare quality
and cost containment
The contributions of mobile health (mhealth) applications to
enhancing healthcare quality and guaranteeing cost containment
in the healthcare sector cannot be underestimated. Mhealth
applications provide good health literacy about hereditary dis-
eases that majority are ignorant of [38]. Health literacy, in turn,
helps to improve general public awareness, thus improving public
health and reducing the amount spent on seeking for healthcare
services.
Mobile health applications can be used to provide support for
the Chronic Care Model. This, in turn, supports self-management
and team-based care for patients living with different types of
chronic diseases [39]; for instance, automated text messaging can
help provide support for patients living with diabetes.
Mhealth applications have also been found useful and resour-
ceful in treatment monitoring and the curbing of the spread of
infectious diseases, such as malaria [40]. Emergency healthcare
process automation can be achieved with mobile health technol-
ogy [41].
Mhealth applications that have sensors, diagnostic and pre-
dictive functions can help ensure cost containment [42,43]. They
can help patients monitor their health status and send real-time
readings of patients’ health conditions to specialist hospitals. They
can help patients to drastically reduce the cost of consultation and
diagnosis. They can also assist patients in avoiding the payment of
consultation fee in seeing a medical doctor, while health applica-
tions that have drug prescriptions and recommender systems have
saved patients the trouble of running around looking for an
authentic pharmacist.
Some mhealth applications can help enhance the quality of infec-
tious disease research [44–46]. This can be achieved by applying such
mhealth-related applications to the ﬁelds of computational biology
and bioinformatics of infectious diseases. In summary, mhealth
applications have numerous beneﬁts.6. Conclusion
The adoption and application of computational knowledge
from mobile informatics, computer programming and knowledgebase domains, to develop an android mobile application on her-
editary diseases and disorders, is a distinctive contribution to
this study.
We have successfully implemented an android mobile application
(AMAHD) that will beneﬁt the scientiﬁc research community. We
conducted experiments which helped us to successfully classify some
hereditary diseases as either common or rare; information about
these have been incorporated into our mobile application.
To some extent, we were also able to integrate artiﬁcial intel-
ligence (“Logical Disjunction Rule-based Algorithm” (LDRA)), into
AMAHD in order to identify symptoms and associate them with
potential hereditary diseases.
The mobile application will help sensitize and complement the
efforts of biomedical, medical and bioinformatics researchers
working in the research areas of heredity and genetics.
Based on the results obtained from the performance evaluation
conducted, AMAHD has proven to be a valuable resource to the
research enterprise in the battle against hereditary diseases and
disorders. For institutions, communities and researchers inter-
ested in adopting AMAHD, the mobile application is freely avail-
able online.
Future work on AMAHD will involve the incorporation of more
hereditary diseases into the database, incorporation of a voice-
enabled interactive facility, and a complete implementation of a
predictive algorithm into the symptoms section of the mobile
application. Extended work can also be done, by integrating text
alerts into AMAHD, which will help a hereditary disease patient
alert a medical doctor for immediate attention and care. We hope
to further enhance the performance of AMAHD by further reﬁning
the computational methods adopted at developing the mobile
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